Giannitrapani, Lydia
 Distribuzione geografica
Continente #
AS - Asia 843
NA - Nord America 608
EU - Europa 299
SA - Sud America 279
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 2
Totale 2.061
Nazione #
US - Stati Uniti d'America 554
SG - Singapore 331
BR - Brasile 220
CN - Cina 147
IT - Italia 117
VN - Vietnam 101
HK - Hong Kong 94
NL - Olanda 54
BD - Bangladesh 52
FR - Francia 46
JP - Giappone 26
GB - Regno Unito 25
IN - India 22
KR - Corea 21
AR - Argentina 20
CA - Canada 18
MX - Messico 17
ID - Indonesia 12
EC - Ecuador 11
DE - Germania 8
PL - Polonia 8
ZA - Sudafrica 8
CO - Colombia 7
ES - Italia 7
PY - Paraguay 6
FI - Finlandia 5
RU - Federazione Russa 5
SE - Svezia 5
VE - Venezuela 5
IL - Israele 4
KH - Cambogia 4
LV - Lettonia 4
NI - Nicaragua 4
PE - Perù 4
PK - Pakistan 4
SA - Arabia Saudita 4
CL - Cile 3
CY - Cipro 3
IQ - Iraq 3
JM - Giamaica 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
GT - Guatemala 2
LT - Lituania 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
AL - Albania 1
AT - Austria 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MA - Marocco 1
PH - Filippine 1
PR - Porto Rico 1
RE - Reunion 1
RS - Serbia 1
SC - Seychelles 1
TN - Tunisia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 2.051
Città #
Singapore 205
Santa Clara 125
Hong Kong 90
Hefei 55
San Jose 53
Ashburn 46
Ho Chi Minh City 41
Beijing 39
Lauterbourg 38
Los Angeles 32
Hanoi 23
Seoul 21
Tokyo 21
São Paulo 18
Milan 16
New York 14
Buffalo 12
Dallas 11
Brasília 9
Brooklyn 9
Montreal 8
Naples 8
Palermo 8
Orem 7
Denver 6
Warsaw 6
Chennai 5
Chicago 5
Guayaquil 5
Mexico City 5
Portsmouth 5
Potenza 5
Stockholm 5
Aracaju 4
Bengaluru 4
Cagliari 4
Dhaka 4
Houston 4
Johannesburg 4
Lima 4
London 4
Manchester 4
Minamishinagawa 4
Newark 4
Phnom Penh 4
Riga 4
Rio de Janeiro 4
Rome 4
Biên Hòa 3
Fortaleza 3
Genoa 3
Germantown 3
Haiphong 3
Helsinki 3
Jakarta 3
Lucca 3
Maceió 3
Madrid 3
Managua 3
Marseille 3
Montevideo 3
Mumbai 3
Nicosia 3
Porto Alegre 3
Posadas 3
Ribeirão Preto 3
San Nicola Manfredi 3
Thái Bình 3
Turin 3
Uberlândia 3
Asunción 2
Bandung 2
Belo Horizonte 2
Belém 2
Bologna 2
Boston 2
Bắc Ninh 2
Cachoeira do Sul 2
Cachoeirinha 2
Camaragibe 2
Camden 2
Campinas 2
Catanduva 2
Catania 2
Clinton 2
Council Bluffs 2
Curitiba 2
Darmstadt 2
Duque de Caxias 2
Figino 2
Florence 2
Formosa 2
Fort Myers 2
Frankfurt am Main 2
Guatemala City 2
Kingston 2
Lancaster 2
Lappeenranta 2
Memphis 2
Miami 2
Totale 1.142
Nome #
EVOO's Effects on Incretin Production: Is There a Rationale for a Combination in T2DM Therapy? 165
The clinical impact of an extra virgin olive oil enriched mediterranean diet on metabolic syndrome: Lights and shadows of a nutraceutical approach 128
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 116
Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: A narrative review of preclinical studies 102
New landscapes and horizons in hepatocellular carcinoma therapy. 99
Sex hormones and risk of liver tumor. 90
The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma 76
NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response 69
COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. 64
Hepatocellular Carcinoma: A Difficult Cancer to Treat 63
The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement? 60
Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population 59
Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis 58
Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma 54
SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease 52
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 45
Can Baseline IL-6 Levels Predict Long COVID in Subjects Hospitalized for SARS-CoV-2 Disease? 44
Phenotypical and Functional Alteration of ?? T Lymphocytes in COVID-19 Patients: Reversal by Statins 42
Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort 42
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. 41
Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-±, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma. 41
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 37
COVID in 2022. Clinical risk management of sars-cov-2 positive patients admitted to an internal medicine ward 34
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 34
G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 32
Atopy and Other Sensitivities in Non-Celiac Wheat Sensitivity: Is There an Associated Hypersensitivity Background? † 32
Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. 31
Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease. 31
Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment. 30
Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. 29
Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. 29
Cyclooxygenase-2, Tumor Necrosis Factor-±, Vascular Endothelial Growth factor-A and IL-6 genes SNPS and Il-6 serum levels in liver cirrhosis and hepatocellular carcinoma. 27
Sex hormones and risk of liver tumors 26
Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study . 26
Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. 25
Frequent alteration of the Yin Yang/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. 25
Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease. 24
IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. 24
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma. 22
Sex hormones and risk of liver tumors 20
Exploring the Impact of Polychlorinated Biphenyls (PCBs) on the Development of MASLD: A Comprehensive Review 13
Totale 2.061
Categoria #
all - tutte 6.846
article - articoli 5.612
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025613 11 4 57 20 98 26 13 22 28 65 149 120
2025/20261.177 34 238 96 204 171 45 116 45 76 57 49 46
2026/2027271 65 90 116 0 0 0 0 0 0 0 0 0
Totale 2.061